Investors

CRAACO is the only program to address how to connect clinical research to clinical care and what it takes to integrate both for better access.  The conference is designed to bring together all of the stakeholders from Pharma companies, Biotechs and CROs, as well as hospital and healthcare systems and physician groups to discuss how this has been done, some of the challenges, and explore the strategies, partnerships, and tools to achieve it.

The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region. It has been connecting life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic life science and healthcare innovation since 2018.

ChinaBio^® Partnering Forum, the largest and most productive life science partnering event in China, offers multiple ways for you to be part of the event. Explore the options below to learn more about how you can get involved.

Biotech Showcase provides biotechnology companies, pharmaceutical executives and investors an opportunity to meet in one place during the world’s largest annual healthcare investor conference.

Over the past 10 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI’s IO Summit provides.

Where the new wave of life science innovators partner to fuel the future of drug development.

BIO-Europe Spring, the premier springtime partnering event, brings together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one meetings.

Connect and engage with a wide range of business leaders, including senior executives of leading biotech
companies, business development teams from pharmaceutical companies and other industry experts.

Baird is delighted to host its annual Global Healthcare Conference. This conference brings institutional and private equity investors together with senior management from over 90 public and privately-held companies. The conference will feature companies across the following sectors: Biotechnology, Healthcare Supply Chain & Pharma Services, Healthcare Information Technology, Life Sciences & Diagnostics, Medical Technology and Facilities & Services. 

AusMedtech is Australia’s premier medical technology conference for medtech executives, providing business partnering opportunities for decision makers and investors.